Company profile
LENSAR Inc
NASDAQ: LNSR · Healthcare · Medical - Equipment & Services
#433 of 1,418 Healthcare companies by revenue58th-percentile growth
EA Score
55CFH 50DQ 57GM 70SS 53
v0.1 · 65/100 weight · provisional
↑ growth stability, filing timeliness · ↓ listing tenure, balance-sheet leverage
Methodology →Revenue TTM
$57.7M
Rev growth YoY (TTM)
+1.1%
Net income (FY)
-$34.3M
Employees
150
as of 2026-08-18
Market cap
$100.8M
as of 2026-08-18
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$51.7M$51.7M2025
Net income-$34.3M-$34.3M2025
Operating income-$24.6M-$24.6M2025
Total assets$71.4M$71.4M2025
Liabilities$83.7M$83.7M2025
Equity-$26.0M-$26.0M2025
Revenue trend
FY2020 – FY2025 · USD
FY20
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Product89%
Service11%
By geography
UNITED STATES66%
Europe16%
Asia Excluding South Korea16%
KOREA, REPUBLIC OF1%
Other Geographical Region0%
The read
What is LENSAR Inc’s revenue?
LENSAR Inc booked $51.7M in FY2025 revenue, growing 12% year over year — about the middle of the pack among Healthcare companies we track, at a -66.4% net margin.
Peers · Healthcare
Vext Science, Inc.64COcular Therapeutix, Inc.62CNeptune Wellness Solutions Inc.——Cipher Pharmaceuticals Inc.84B+Carlsmed, Inc.54DMinerva Surgical, Inc.——Neighbors
Orange →Key facts
CEONicholas T. Curtis
SectorHealthcare
IndustryMedical - Equipment & Services
HeadquartersOrlando, FL
ExchangeNASDAQ: LNSR
Employees150
IPO date2020-10-02
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.